Endoscopic Submucosal Dissection/ESD Market: Growth, Size, Share, and Trends

Report Code MD 8538
Published in Jul, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Endoscopic Submucosal Dissection/ESD Market by Product (Gastroscopes & Endoscopes, Injection Agent, Tissue Retractor), Indication (Stomach Cancer, Colon Cancer), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Center) - Global Forecast to 2030

Overview

The global endoscopic submucosal dissection market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.75 billion by the end of the period. The increasing adoption of endoscopic submucosal dissection (ESD) in Western countries is becoming a significant growth driver for the global ESD market. While Japan and South Korea have historically led in procedural volume due to early adoption and robust screening programs, North America and Europe are now integrating ESD into routine clinical practice. This shift is driven by a growing awareness of the procedure’s curative potential, along with improved access to training through international fellowships, live demonstration courses, and hands-on workshops.

Additionally, the publication of clinical guidelines by leading gastroenterological societies in Western countries has legitimized the use of ESD for treating early-stage gastric, esophageal, and colorectal lesions. Advancements in endoscopic technology, coupled with an increasing number of specialized centers of excellence, are further accelerating this adoption. As ESD gains acceptance and support within Western healthcare systems—particularly due to favorable reimbursement frameworks—its procedural volume is expected to rise, significantly boosting market expansion.

Endoscopic Submucosal Dissection Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Endoscopic Submucosal Dissection Market

Asia Pacific

Market growth in APAC can be attributed to the improving healthcare infrastructure and growing patient population

The market for endoscopic submucosal dissection is mainly driven by the increasing use of endoscopy in detection and treatment procedures and the rising prevalence of cancer.

Expansions would offer lucrative opportunities for market players in the next five years.

The European market is projected to reach USD 203.1 million by 2030, at a CAGR of 9.1% during the forecast period.

Asia Pacific is the largest regional market for endoscopic submucosal dissection products.

Global Endoscopic Submucosal Dissection Market Dynamics

DRIVER: Increasing use of endoscopy in detection and treatment procedures

The growing use of endoscopy in diagnostic and therapeutic procedures is a major factor driving the growth of the endoscopic submucosal dissection (ESD) market. As the global incidence of gastrointestinal cancers, such as colorectal, gastric, and esophageal cancers, continues to rise, healthcare systems are focusing on early detection and minimally invasive treatment options. Endoscopy has become the primary method for identifying and removing precancerous and cancerous lesions in the gastrointestinal (GI) tract. ESD is a minimally invasive surgical technique that is performed through small incisions using tiny cameras, tubes, and precision instruments. This technique is increasingly being adopted to treat submucosal tumors and lesions, including Barrett’s esophagus, early-stage colorectal, gastric, and esophageal cancers, as well as colon polyps. ESD allows for the en bloc resection of superficial tumors without the need for open surgery, significantly reducing patient trauma.

RESTRAINT: Dearth of skilled professionals

Endoscopic submucosal dissection (ESD) requires high levels of precision, advanced endoscopic handling skills, and in-depth anatomical knowledge to perform safe and complete en bloc resections, particularly in complex anatomical areas like the esophagus or colon. Unlike basic endoscopic techniques, ESD necessitates extensive training and hands-on experience, which are not commonly available in many regions, especially in low- and middle-income countries.

Even in advanced healthcare systems, the number of gastroenterologists or surgeons skilled in ESD remains limited. This is largely because many medical training programs emphasize standard polypectomy or Endoscopic Mucosal Resection (EMR) techniques over ESD. As a result, the availability of ESD procedures is confined to select tertiary care centers, which hinders patient access and slows down market penetration.

Additionally, the risk of complications such as perforation or bleeding when performed by inexperienced practitioners creates hesitation among institutions to adopt the procedure widely. This reluctance contributes to a bottleneck in ESD adoption, even though the technique offers significant clinical advantages.

 

OPPORTUNITY: Growing demand for minimally invasive procedures

The increasing global demand for minimally invasive procedures presents a significant opportunity for the endoscopic submucosal dissection (ESD) market. Both patients and healthcare providers are favoring treatments that offer reduced pain, shorter recovery times, minimal hospital stays, and lower risks of complications—all characteristics of minimally invasive approaches like ESD. Unlike traditional surgeries that may require organ resection and extended hospital stays, ESD allows for the en bloc resection of superficial gastrointestinal tumors using an endoscope. This technique preserves organ function and greatly enhances post-procedural quality of life.

This trend is particularly noticeable in oncology, where rising early-stage cancer detection rates, driven by increased screening, are creating a larger pool of patients eligible for such procedures. Additionally, growing patient awareness, advancements in endoscopic imaging technologies, and the expansion of outpatient surgical infrastructure are further promoting the acceptance of ESD. As healthcare systems move towards value-based care models that emphasize clinical outcomes and cost-efficiency, ESD emerges as a promising alternative, paving the way for new opportunities for market growth.

CHALLENGES: Higher rate of complications

A significant challenge in the endoscopic submucosal dissection (ESD) market is the higher rate of complications, which limits its widespread adoption despite its clinical benefits. ESD is a technically demanding procedure that involves dissecting the deeper layers of the gastrointestinal wall to remove lesions in one piece. This complexity inherently increases the risk of adverse events, particularly bleeding and perforation, occurring in approximately 5% to 10% of cases, depending on factors such as lesion size, location, and the operator's experience.

For instance, colonic ESD carries a higher risk of perforation—up to 15%—due to the thinner wall of the bowel, compared to gastric or esophageal ESD. These complications can lead to emergency surgical interventions, extended hospital stays, or additional treatments, which undermine the minimally invasive advantages that the procedure offers.

Global Endoscopic Submucosal Dissection Market Ecosystem Analysis

The endoscopic submucosal dissection (ESD) market features a structured value chain that includes raw material suppliers, manufacturers, distributors, and end users. Key suppliers like Olympus and FUJIFILM, along with third-party providers such as BD and STERIS, contribute to device production. Leading manufacturers, including Medtronic and Boston Scientific, produce various ESD instruments like electrosurgical knives and injection needles. Distribution is managed by companies like Olympus and FUJIFILM through robust networks. Major end users include hospitals and cancer centers such as Memorial Sloan Kettering and MD Anderson, which are pivotal for ESD procedures targeting early-stage gastrointestinal cancers.

Endoscopic Submucosal Dissection Market Ecosystem
 

By product, the gastroscopes & endoscopes segment hold the largest share of the global endoscopic submucosal dissection market.

The expansion of gastrointestinal (GI) cancer screening programs, particularly in Japan, South Korea, and China, is significantly increasing the detection of early-stage gastric and colorectal lesions. These national initiatives are driving up the demand for both diagnostic and therapeutic endoscopy procedures, with endoscopic submucosal dissection (ESD) becoming a preferred treatment option for early neoplasms. Consequently, there is a growing need for high-performance visualization tools. Gastroscopes & endoscopes, which are essential for both diagnosis and ESD treatment, hold the largest market share in the ESD market due to their vital role.

By indication, the stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market.

The widespread use of narrow-band imaging (NBI) and chromoendoscopy in gastric cancer screening has significantly improved the early detection of lesions and the accurate delineation of their margins. These advanced visualization techniques allow endoscopists to identify subtle changes in the mucosa and assess the boundaries of lesions with precision, which is crucial for effective Endoscopic Submucosal Dissection (ESD) planning and execution. By integrating these methods into routine screening protocols—especially in regions with high incidences of gastric cancer like Japan and South Korea—there has been an increase in ESD procedures for gastric tumors. As a result, the stomach cancer segment has become the largest in the ESD market.

The Asia Pacific accounted for the largest share of the global endoscopic submucosal dissection market in 2024.

The rise of medical tourism in endoscopy is significantly boosting the growth of the Endoscopic Submucosal Dissection (ESD) market, especially in the Asia Pacific region. International patients are increasingly traveling to countries like Japan, South Korea, and India to access advanced endoscopic procedures such as ESD. They are attracted by lower treatment costs and the high level of expertise among endoscopists in these countries. Additionally, these nations offer state-of-the-art technology and well-established screening programs, making them preferred destinations for gastrointestinal interventions. As a result, the Asia-Pacific region holds the largest market share in the ESD market, driven by a high volume of cross-border procedures.

HIGHEST CAGR (2025–2030)
US FASTEST-GROWING MARKET IN REGION
Endoscopic Submucosal Dissection Market Region

Recent Developments of Endoscopic Submucosal Dissection Market

  • Product Launch: In May 2025, FUJIFILM introduced the ELUXEO 800 series therapeutic gastroscopes (models EG 840T/TP) optimized for advanced treatments, including ESD, featuring enhanced ACI imaging, dual-channel support, 3.2 mm working channel, and 160° downward angulation.
  • Expansion: In September 2022, Olympus invested EUR 32 million in new medical equipment repair facilities. The facility will be Olympus’ highest volume repair center in Europe.
  • Agreement: In May 2022, Creo Medical signed a long-term, multi-year collaboration agreement with Intuitive to optimize certain Creo products to be compatible with the robotic technology of Intuitive.
  • Acquisition: In May 2021, STERIS (Ireland) acquired Cantel Medical (US). This acquisition enabled STERIS Healthcare to expand the reach of its products and services to customers across the world. The deal size was USD 4.6 billion.

Key Market Players

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million)
Segments covered Product, Indication, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries

Key Questions Addressed by the Report

What are the key drivers supporting the market growth of endoscopic submucosal dissection?

The increasing use of endoscopy in detection and treatment procedures and the rising prevalence of cancer are the key drivers fueling the growth of the endoscopic submucosal dissection market.

What are the challenges in adopting endoscopic submucosal dissection?

The higher rate of complications and the risk of post-operative infections may hinder market growth.

Which was the largest product segment of the endoscopic submucosal dissection market in 2024?

In 2024, the gastroscopes & endoscopes segment held the largest share of the global endoscopic submucosal dissection market. Advancements in high-definition (HD) and 4K ultra-high-definition (UHD) imaging technologies have revolutionized ESD procedures by offering superior optical clarity and detailed visualization. As a result, gastroscopes & endoscopes, integral to these imaging advancements, hold the largest market share in the ESD market, driven by their critical role in procedural success.

Which country/region occupies the largest share of the endoscopic submucosal dissection market globally?

The Asia Pacific is expected to account for the largest share of the ESD market during the forecast period. Government-funded screening programs in Japan and Korea actively promote early detection of gastric and colorectal lesions using endoscopy, significantly increasing ESD volumes.

What is the total CAGR expected for the endoscopic submucosal dissection market during 2025−2030?

The endoscopic submucosal dissection market is expected to grow at a CAGR of 8.4% during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Endoscopic Submucosal Dissection/ESD Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
23
RESEARCH METHODOLOGY
28
EXECUTIVE SUMMARY
43
PREMIUM INSIGHTS
46
MARKET OVERVIEW
50
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing use of endoscopy in detection and treatment procedures
    - Rising prevalence of cancer
    - Growing geriatric population
    RESTRAINTS
    - Dearth of skilled professionals
    - High overhead cost of ESD procedures with limited reimbursements
    OPPORTUNITIES
    - Growing demand for minimally invasive procedures
    - Expected increase in adoption of and preference for ESD procedures in developing countries
    CHALLENGES
    - Higher rate of complications
    - Risk of post-operative infection
  • 5.3 INDUSTRY TRENDS
    ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
    ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
  • 5.4 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY LANDSCAPE
    - North America
    - Europe
  • 5.5 MARKET ECOSYSTEM
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    - High capital requirement
    - High preference for products from well-established brands
    THREAT OF SUBSTITUTES
    - Presence of substitute therapies for endoscopic submucosal dissection
    BARGAINING POWER OF SUPPLIERS
    - Presence of several raw material suppliers
    - Supplier switching cost
    BARGAINING POWER OF BUYERS
    - Limited number of companies offering premium products at global level
    INTENSITY OF COMPETITIVE RIVALRY
    - Increasing demand for high-quality and innovative products
    - Lucrative growth potential in emerging markets
  • 5.8 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024
    AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)
  • 5.9 PATENT ANALYSIS
  • 5.10 SUPPLY CHAIN ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS DURING 2025–2025
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 TRENDS/DISRUPTIONS AFFECTING CUSTOMER BUSINESS
    TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
  • 5.14 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.15 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Endoscopic electrosurgical knives
    - High-definition endoscopes
    COMPLEMENTARY TECHNOLOGIES
    - Narrow band imaging/i-scan/FICE
    - Optical coherence tomography (OCT)
    ADJACENT TECHNOLOGIES
    - Endoscopic mucosal resection
    - Full-thickness resection devices
  • 5.16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ADJACENT MARKET
  • 5.17 CASE STUDY ANALYSIS
    ROBOTIC-ASSISTED ESD FOR ESOPHAGEAL TUMORS
    COST-EFFECTIVE ESD DEVICES FOR STOMACH CANCER
    PRECISION ESD FOR COLORECTAL CANCER LESIONS
  • 5.18 IMPACT OF AI/GEN AI ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    MARKET POTENTIAL OF AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI
    FUTURE OF GENERATIVE AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • 5.19 IMPACT OF 2025 US TARIFF ON ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON END-USE INDUSTRIES
  • 5.20 INVESTMENT & FUNDING SCENARIO
ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT
92
  • 6.1 INTRODUCTION
  • 6.2 GASTROSCOPES & COLONOSCOPES
    RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
  • 6.3 KNIVES
    IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
  • 6.4 INJECTION AGENTS
    NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
  • 6.5 TISSUE RETRACTORS
    RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION
  • 6.6 GRASPERS/CLIPS
    PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE DEMAND
  • 6.7 OTHER PRODUCTS
ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION
103
  • 7.1 INTRODUCTION
  • 7.2 STOMACH CANCER
    SIGNIFICANT PROPORTION OF CANCER DEATHS TO DRIVE SEGMENT
  • 7.3 COLON CANCER
    INTEREST BY MEDICAL DEVICE MANUFACTURERS, CLINICAL INVESTIGATORS, AND PRACTICING CLINICIANS TO DRIVE MARKET
  • 7.4 ESOPHAGEAL CANCER
    GROWING PREVALENCE OF ESOPHAGEAL CANCER TO FUEL GROWTH
ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER
111
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
  • 8.3 SPECIALTY CLINICS
    TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
  • 8.4 AMBULATORY SURGICAL CENTERS
    GROWTH IN SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
  • 8.5 OTHER END USERS
ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION
118
  • 9.1 INTRODUCTION
  • 9.2 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Supportive medical device reimbursement policies to drive market growth
    CHINA
    - Large patient population and strong need for healthcare infrastructure improvements to boost market growth
    INDIA
    - Favorable government initiatives for healthcare infrastructure improvements to support market growth
    SOUTH KOREA
    - Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
    AUSTRALIA
    - High incidence of cancer to propel market growth
    REST OF ASIA PACIFIC
  • 9.3 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Largest market for endoscopic submucosal dissection products
    CANADA
    - Slower healthcare development over past decade to restrain growth
  • 9.4 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Germany to account for largest share of European market
    FRANCE
    - High-quality healthcare system offering coverage to all citizens to support market growth
    UK
    - Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
    ITALY
    - Receptivity of government toward high-quality and technologically advanced equipment to foster growth
    SPAIN
    - Rising prevalence of cancer to drive market growth
    REST OF EUROPE
  • 9.5 LATIN AMERICA
    INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY TO FAVOR MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Increase in private healthcare investments and rise in medical tourism to aid market growth
    MEXICO
    - Increased government investment in healthcare infrastructure and technological advancements to aid market growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE TO CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    INCREASING INVESTMENT IN HEALTHCARE INFRASTRUCTURE AND GROWING MEDICAL TOURISM TO PROPEL MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
166
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product footprint
    - Indication footprint
    - End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
187
  • 11.1 KEY PLAYERS
    OLYMPUS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - MnM view
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - MnM view
    SUMITOMO BAKELITE CO., LTD.
    - Business overview
    - Products offered
    - MnM view
    CREO MEDICAL GROUP PLC
    - Business overview
    - Products offered
    - Recent developments
    HOYA CORPORATION
    - Business overview
    - Products offered
    CONMED CORPORATION
    - Business overview
    - Products offered
    STERIS
    - Business overview
    - Products offered
    - Recent developments
    MTW ENDOSKOPIE MANUFAKTUR
    - Business overview
    - Products offered
    OVESCO ENDOSCOPY AG
    - Business overview
    - Products offered
    ZEON MEDICAL INC.
    - Business overview
    - Products offered
    MICRO-TECH ENDOSCOPY
    - Business overview
    - Products offered
    - Recent developments
    KARL STORZ SE & CO. KG
    - Business overview
    - Products offered
    COOK MEDICAL
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER COMPANIES
    LEO MEDICAL CO., LTD.
    ERBE ELEKTROMEDIZIN GMBH
    TAEWOONG MEDICAL CO., LTD.
    DCC HEALTHCARE
    KOSSEN CO., LTD.
    INNOVAMEDICA S.P.A.
    JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
    BEIJING ZKSK TECHNOLOGY CO., LTD.
    UPEX-MED CO., LTD.
APPENDIX
226
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ROLE IN ECOSYSTEM
  • TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 9 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 (USD)
  • TABLE 10 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)
  • TABLE 11 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY PATENTS, 2023–2025
  • TABLE 12 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: CONFERENCES AND EVENTS, 2025–2026
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • TABLE 14 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 15 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 16 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 17 TYPES OF ELECTROSURGICAL KNIVES: FEATURES & USE CASES
  • TABLE 18 KEY COMPANIES IMPLEMENTING AI
  • TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 20 KEY PRODUCT-RELATED TARIFFS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
  • TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 22 GASTROSCOPES & COLONOSCOPES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 23 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 24 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023–2030
  • TABLE 25 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 26 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023–2030
  • TABLE 27 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023–2030
  • TABLE 29 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 30 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023–2030
  • TABLE 31 OTHER PRODUCTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 (NUMBER OF PROCEDURES)
  • TABLE 34 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2022–2040)
  • TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 37 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2022–2040)
  • TABLE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 40 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2022–2040)
  • TABLE 41 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2024 (NUMBER OF PROCEDURES)
  • TABLE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 44 HOSPITALS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 SPECIALTY CLINICS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 AMBULATORY SURGICAL CENTERS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 53 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 54 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 55 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 56 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 57 CHINA: MACROECONOMIC INDICATORS
  • TABLE 58 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 59 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 60 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 61 INDIA: MACROECONOMIC INDICATORS
  • TABLE 62 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 63 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 64 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 65 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 66 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 67 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 68 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 69 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 70 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 71 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 72 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 73 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 74 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 75 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 80 US: MACROECONOMIC INDICATORS
  • TABLE 81 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 82 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 83 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 84 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
  • TABLE 85 CANADA: MACROECONOMIC INDICATORS
  • TABLE 86 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 87 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 88 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 90 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 91 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 92 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 93 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 94 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 95 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 96 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 97 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 98 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 99 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 100 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 101 UK: MACROECONOMIC INDICATORS
  • TABLE 102 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 103 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 104 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 105 ITALY: MACROECONOMIC INDICATORS
  • TABLE 106 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 107 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 108 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 109 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 110 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 111 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 112 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 113 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 114 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 115 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 116 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 119 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 120 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 121 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 122 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 123 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 124 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 125 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 126 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 127 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 128 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 129 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 130 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 134 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 137 KEY DEVELOPMENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, JANUARY 2021–JUNE 2025
  • TABLE 138 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : DEGREE OF COMPETITION
  • TABLE 139 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : REGION FOOTPRINT
  • TABLE 140 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT FOOTPRINT
  • TABLE 141 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: INDICATION FOOTPRINT
  • TABLE 142 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: END USER FOOTPRINT
  • TABLE 143 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY STARTUPS/SMES
  • TABLE 144 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
  • TABLE 145 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT
  • TABLE 146 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
  • TABLE 147 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS, JANUARY 2021–JUNE 2025
  • TABLE 148 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: EXPANSIONS, JANUARY 2021–JUNE 2025
  • TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW
  • TABLE 150 OLYMPUS CORPORATION: PRODUCTS OFFERED
  • TABLE 151 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JUNE 2025
  • TABLE 152 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025
  • TABLE 153 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 154 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 155 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • TABLE 156 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 157 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2025
  • TABLE 158 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2025
  • TABLE 159 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
  • TABLE 160 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 161 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
  • TABLE 162 SUMITOMO BAKELITE CO., LTD.: PRODUCTS OFFERED
  • TABLE 163 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
  • TABLE 164 CREO MEDICAL GROUP PLC: PRODUCTS OFFERED
  • TABLE 165 CREO MEDICAL GROUP PLC: DEALS, JANUARY 2021–JUNE 2025
  • TABLE 166 CREO MEDICAL GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025
  • TABLE 167 HOYA CORPORATION: BUSINESS OVERVIEW
  • TABLE 168 HOYA CORPORATION: PRODUCTS OFFERED
  • TABLE 169 CONMED CORPORATION: BUSINESS OVERVIEW
  • TABLE 170 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 171 STERIS: COMPANY OVERVIEW
  • TABLE 172 STERIS: PRODUCTS OFFERED
  • TABLE 173 STERIS: DEALS
  • TABLE 174 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
  • TABLE 175 MTW ENDOSKOPIE MANUFAKTUR: PRODUCTS OFFERED
  • TABLE 176 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
  • TABLE 177 OVESCO ENDOSCOPY AG: PRODUCTS OFFERED
  • TABLE 178 ZEON MEDICAL INC.: BUSINESS OVERVIEW
  • TABLE 179 ZEON MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 180 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
  • TABLE 181 MICRO-TECH ENDOSCOPY: PRODUCTS OFFERED
  • TABLE 182 MICRO-TECH ENDOSCOPY: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
  • TABLE 183 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
  • TABLE 184 KARL STORZ SE & CO. KG.: PRODUCTS OFFERED
  • TABLE 185 COOK MEDICAL: BUSINESS OVERVIEW
  • TABLE 186 COOK MEDICAL: PRODUCTS OFFERED
  • TABLE 187 COOK MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
  • TABLE 188 LEO MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 189 ERBE ELEKTROMEDIZIN GMBH: COMPANY OVERVIEW
  • TABLE 190 TAEWOONG MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 191 DCC HEALTHCARE: COMPANY OVERVIEW
  • TABLE 192 KOSSEN CO., LTD.: COMPANY OVERVIEW
  • TABLE 193 INNOVAMEDICA S.P.A.: COMPANY OVERVIEW
  • TABLE 194 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 195 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 196 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 197 UPEX-MED CO., LTD.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2024)
  • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
  • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 12 TOP-DOWN APPROACH
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
  • FIGURE 19 GASTROSCOPES & COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024
  • FIGURE 20 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 ASIA PACIFIC TO BE LARGEST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 GLOBAL CANCER INCIDENCE, 2022–2050
  • FIGURE 25 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD)
  • FIGURE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: TOP PATENT OWNERS/APPLICANTS AND NUMBER OF PATENTS GRANTED, JANUARY 2015–JUNE 2025
  • FIGURE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 33 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024
  • FIGURE 34 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 35 KEY FEATURES OF GEN AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • FIGURE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION)
  • FIGURE 37 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
  • FIGURE 39 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
  • FIGURE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2020–2024 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
  • FIGURE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY FOOTPRINT
  • FIGURE 45 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 49 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 53 SUMITOMO BAKELITE CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 54 CREO MEDICAL GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 55 HOYA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 STERIS: COMPANY SNAPSHOT

 

The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

Secondary Research

This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

Primary Research

During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

Breakdown of Primary Interviews

Endoscopic Submucosal Dissection Market

Note 1: C-level executives include CEOs, COOs, and CTOs.

Note 2: Others include sales, marketing, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Endoscopic Submucosal Dissection Market

Data Triangulation

The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

Stakeholders

  • Manufacturers of endoscopes and related devices
  • Suppliers and distributors of endoscopy devices
  • Hospitals, diagnostic centers, and medical colleges
  • Independent surgeons and private offices of physicians
  • Ambulatory surgery centers (ASCs)
  • Teaching hospitals and academic medical centers
  • Government bodies/municipal corporations
  • Business research and consulting service providers
  • Venture capitalists
  • US Food and Drug Administration (US FDA)
  • European Union (EU)

Report Objectives

  • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
  • To strategically profile the key players in the global market and comprehensively analyze their core competencies
  • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

Previous Versions of this Report

Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) & Region - Global Forecasts to 2027

Report Code MD 8538
Published in Jan, 2023, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Endoscopic Submucosal Dissection/ESD Market

Kahlill

Feb, 2023

what are the top 3 use cases of endoscopic submucosal dissection market in near future?.

DMCA.com Protection Status